A Phase II Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia

PHASE2CompletedINTERVENTIONAL
Enrollment

189

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Community Acquired Pneumonia
Interventions
DRUG

Faropenem(high dose group)

dosage form: Injection dosage:2400 mg frequency: Three times a day

DRUG

Faropenem(low-dose group)

dosage form: Injection dosage:2400 mg frequency: twice a day

DRUG

Ertapenem

dosage form: Injection dosage:1000 mg frequency: once a day

Trial Locations (9)

200040

Huashan Hospital ,Fudan University, Shanghai

230001

Anhui Provincial Hospital, Hefei

266000

Qingdao Municipal Hospital, Qingdao

300211

The Second Hospital of Tianjin Medical University, Tianjin

442000

Taihe Hospital in Shiyan City, Shiyan

510080

First Affiliated Hospital of Sun Yat-sen University, Guangzhou

510120

Sun Yat-sen Memorial Hospital Sun Yat-sen University, Guangzhou

510630

The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou

Unknown

The Second Hospital of Jilin University, Changchun

All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY